Loading…

Serres Group Oy became the majority shareholder of Innokas Medical Group, investing 4 million euros in the company. The acquisition aims to develop Innokas Medical into a leading co-creation partner in medical technology.
“Serres’ aim is to develop Innokas Medical to become a leading co-creation partner in medical technology globally.”blog.innokasmedical.fi
Summarized from public sources; check the original articles before acting on it.